Axsome Therapeutics (AXSM) P/S US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/S | ? | 62.7 | 13.4 | 9.16 | |||||
Changes by years, y/y, % | -79% | -78.7% |
Axsome Therapeutics. P/S
Axsome Therapeutics. P/S, changes, %
Axsome Therapeutics (AXSM) P/S US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/S | ? | 14.7 | 13.9 | 15.1 | 13.1 | 12.8 | 9.16 | |
Changes by years, y/y, % | -80% | -79% | -19% | -24% | -13% | |||
Changes by quarters, q/q, % | -14% | -6% | +8% | -13% | -3% |